NCT00157963View on ClinicalTrials.gov

Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)

PHASE4CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

February 5, 2005

Primary Completion Date

February 8, 2006

Study Completion Date

February 8, 2006

Conditions
Essential Hypertension
Interventions
DRUG

MK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00157963 - Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) | Biotech Hunter | Biotech Hunter